Americans Robert Lefkowitz and Brian Kobilka have been awarded the 2012 Nobel Prize in Chemistry for their "groundbreaking discoveries" about the "fine-tuned system of interactions between billions of cells" in the human body, the Nobel Prize committee announced this morning.

This year's winners of the Chemistry Nobel: Robert Lefkowitz (left) and Brian Kobilka.

This year's winners of the Chemistry Nobel: Robert Lefkowitz (left) and Brian Kobilka.

On Morning Edition, NPR's Nell Greenfieldboyce said the scientists' work has been "hugely important" because as they have unraveled the structure of the body's "G-protein-coupled receptors," that has helped researchers see the receptors in action. And because "about half of all pharmaceuticals act on receptors," understanding how they work is important when treating diseases.

According to the Nobel committee:

"For a long time, it remained a mystery how cells could sense their environment. Scientists knew that hormones such as adrenalin had powerful effects: increasing blood pressure and making the heart beat faster. They suspected that cell surfaces contained some kind of recipient for hormones. But what these receptors actually consisted of and how they worked remained obscured for most of the 20th Century.

"Lefkowitz started to use radioactivity in 1968 in order to trace cells' receptors. He attached an iodine isotope to various hormones, and thanks to the radiation, he managed to unveil several receptors, among those a receptor for adrenalin: -adrenergic receptor. His team of researchers extracted the receptor from its hiding place in the cell wall and gained an initial understanding of how it works.

"The team achieved its next big step during the 1980s. The newly recruited Kobilka accepted the challenge to isolate the gene that codes for the -adrenergic receptor from the gigantic human genome. His creative approach allowed him to attain his goal. When the researchers analyzed the gene, they discovered that the receptor was similar to one in the eye that captures light. They realized that there is a whole family of receptors that look alike and function in the same manner.

"Today this family is referred to as G-proteincoupled receptors. About a thousand genes code for such receptors, for example, for light, flavour, odour, adrenalin, histamine, dopamine and serotonin. About half of all medications achieve their effect through G-proteincoupled receptors.

"The studies by Lefkowitz and Kobilka are crucial for understanding how G-proteincoupled receptors function. Furthermore, in 2011, Kobilka achieved another break-through; he and his research team captured an image of the -adrenergic receptor at the exact moment that it is activated by a hormone and sends a signal into the cell. This image is a molecular masterpiece the result of decades of research."

Excerpt from:
Chemistry Nobel Goes To Scientists Who Studied Body's Receptors

STOCKHOLM Americans Robert Lefkowitz and Brian Kobilka won the 2012 Nobel Prize in chemistry on Wednesday for studies of protein receptors that let body cells sense and respond to outside signals. Such studies are key for developing better drugs.

The Royal Swedish Academy of Sciences said the two researchers had made groundbreaking discoveries on an important family of receptors, known as G-protein-coupled receptors.

About half of all medications act on these receptors, so learning about them will help scientists to come up with better drugs.

The human body has about 1,000 kinds of such receptors, which let it respond to a wide variety of chemical signals, like adrenaline. Some receptors are in the nose, tongue and eyes, and let us sense smells, tastes and vision.

Lefkowitz, 69, is an investigator at the Howard Hughes Medical Institute and professor at Duke University Medical Center in Durham, North Carolina. Kobilka, 57, is a professor at Stanford University School of Medicine in California.

'My wife gave me an elbow' "I'm feeling very, very excited," Lefkowitz told a news conference in Stockholm by phone.

He said he was fast asleep when the Nobel committee called.

"I did not hear it ... I wear earplugs, so my wife gave me an elbow," he said. "And there it was. ... It was a total shock and surprise."

Lefktowitz said he had no clue that he was being considered for the Nobel Prize, though he added it has always been "a bit of a fantasy" to receive the award.

Kobilka said he found out around 2:30 a.m., after the Nobel committee called his home twice. He said he didn't get to the phone the first time, but that when he picked up the second time, he spoke to five members of the committee.

Visit link:
Americans win Nobel prize for chemistry

STOCKHOLM (AP) Americans Robert Lefkowitz and Brian Kobilka won the 2012 Nobel Prize in chemistry Wednesday for studies of protein receptors that let body cells sense and respond to outside signals. Such studies are key for developing better drugs.

The Royal Swedish Academy of Sciences said the two researchers had made groundbreaking discoveries, mainly in the 1980s, on an important family of receptors, known as G-protein-coupled receptors.

About half of all medications act on these receptors, so learning about them will help scientists to come up with better drugs.

The human body has about 1,000 kinds of such receptors, structures on the surface of cells, which let the body respond to a wide variety of chemical signals, like adrenaline. Some receptors are in the nose, tongue and eyes, and let us sense smells, tastes and light.

Lefkowitz, 69, is an investigator at the Howard Hughes Medical Institute and professor at Duke University Medical Center in Durham, North Carolina.

Kobilka, 57, is a professor at Stanford University School of Medicine in California.

Lefkowitz said he was fast asleep when the Nobel committee called, but he didn't hear it because he was wearing ear plugs. So his wife picked up the phone.

"She said, 'There's a call here for you from Stockholm,'" Lefkowitz told The Associated Press. "I knew they ain't calling to find out what the weather is like in Durham today."

He said he didn't have an "inkling" that he was being considered for the Nobel Prize.

"Initially, I expected I'd have this huge burst of excitement. But I didn't. I was comfortably numb," Lefkowitz said.

Read the rest here:
2 US scientists win Nobel chemistry prize

(Reuters) - Here is a look at the 2012 Nobel Prize for Chemistry, which was awarded on Wednesday to Americans Robert Lefkowitz and Brian Kobilka for "for studies of G-protein-coupled receptors".

The 2012 prize was awarded for having mapped how a family of receptors called G-protein- coupled receptors (GPCRs) work. In this family, there are receptors for adrenalin, dopamine, serotonin, light, flavor and odor. Most physiological processes depend on GPCRs. Around half of all medications act through these receptors, among them beta blockers, antihistamines and various kinds of psychiatric medications.

103 Nobel Prizes in Chemistry have been awarded to 160 laureates from 1901-2011. Frederick Sanger won the prize twice.

Only four are women. Two of the four, Marie Curie and Dorothy Crowfoot Hodgkin, won unshared Chemistry Prizes.

Some Famous Winners: The Curies were the most successful "Nobel Prize family". The husband-and-wife partnership of Marie Curie and Pierre Curie were awarded the 1903 Nobel Prize in Physics. Marie Curie herself won the 1911 chemistry prize. Their daughter Irne Joliot-Curie was awarded the 1935 Nobel Prize in Chemistry, together with her husband, Frdric Joliot.

Adolf Hitler forbade two German winners from receiving the prize, Richard Kuhn in 1938 and Adolf Butenandt in 1939.

Sources: Reuters, http://nobelprize.org. Chambers Biographical Dictionary.

(Reporting by David Cutler, London Editorial Reference Unit)

Follow this link:
Factbox: A look at the Nobel Chemistry Prize

Two U.S. scientists won the Nobel Prize in Chemistry for discovering how cell receptors involved in about half of all medicines work.

Robert J. Lefkowitz, 69, of Duke University Medical Center in Durham, North Carolina, and Brian K. Kobilka, 57, of Stanford University School of Medicine in Palo Alto, California, will share the 8 million-krona ($1.2 million) award, the Royal Swedish Academy of Sciences said at a news conference today.

They received the prize for their work on cells and sensibility, the academy said. The men exposed the inner workings of the largest and most pervasive family of cell receptors, known as G-protein-coupled.

Lodged in the fatty membranes that surround cells, they are the bodys mechanism to read its environment and play a role in sight, smell, taste, as well as pain tolerance and blood pressure. The receptors are the targets of about half of all medicines, the academy said.

Thanks to the work of Robert Lefkowitz and Brian Kobilka, we know what the receptor looks like in the finest molecular detail and we also know its just one of a huge family of receptors, Sven Lidin, a member of the Nobel committee for chemistry, said at the Stockholm news conference. Knowing how they work helps us to make better drugs with fewer side effects.

Lefkowitz, a professor of medicine at Duke and an investigator at the Howard Hughes Medical Institute, said he didnt have a clue he would be in the running for the prize.

I did not go to sleep last night waiting for this call, he said by telephone at the news conference. Im feeling very, very excited. I was fast asleep and the phone rang and I didnt hear it. I wear earplugs when I sleep and my wife gave me an elbow.

He was planning on going to the office and getting haircut today though the haircut will have to wait because he said it will be a crazy day at the office.

Last years Nobel in chemistry was awarded to Dan Shechtman for his discovery of quasicrystals, which changed the prevailing views about the atomic structure of matter.

Annual prizes for achievements in physics, chemistry, medicine, peace and literature were established in the will of Alfred Nobel, the Swedish inventor of dynamite, who died in 1896. The Nobel Foundation was established in 1900 and the prizes were first handed out the following year. The Swedish science academy chooses the chemistry and physics winners.

Here is the original post:
U.S. Scientists Share Chemistry Nobel for Cell Receptors

Research by Robert J. Lefkowitz, left, and Brian K. Kobilka has increased understanding of how cells sense chemicals.

STORY HIGHLIGHTS

(CNN) -- Two American scientists won the Nobel Prize in chemistry Wednesday for their work revealing protein receptors that tell cells what is going on in and around the human body. Their achievements have allowed drug makers to develop medication with fewer side effects.

Research spanning four decades by Robert J. Lefkowitz and Brian K. Kobilka on "G-protein-coupled receptors" has increased understanding of how cells sense chemicals in the bloodstream and external stimuli like light, according to the Royal Swedish Academy of Sciences, which awarded the prize.

Lefkowitz began the research by tracking adrenalin receptors. The Nobel Prize announcement apparently set off some of the excitement hormone in his own body.

"I'm feeling very, very excited," he said in a predawn phone call from the United States to the committee in Stockholm, Sweden, which announced the winners at 5:45 a.m. ET.

"Did I even have any inkling that it was coming?" Lefkowitz said. "I'd have to say no."

He contacted Kobilka via a Skype video call to celebrate the news after receiving the call from the Nobel committee.

Lefkowitz, with the Howard Hughes Medical Institute and Duke University Medical Center in Durham, North Carolina, began tracking cell receptors with radioactive substances in 1968.

In the 1980s, Kobilka, from Stanford University School of Medicine in California, joined the research to isolate the human gene that produces the adrenalin receptor, the academy said.

Here is the original post:
Americans Robert J. Lefkowitz, Brian K. Kobilka win Nobel Prize in chemistry

STOCKHOLM (Reuters) - Two American scientists won the 2012 Nobel Prize for chemistry on Wednesday for research into how cells respond to external stimuli that is helping to develop better drugs to fight diseases such as diabetes, cancer and depression.

The Royal Swedish Academy of Sciences said the 8 million crown ($1.2 million) prize went to Robert Lefkowitz, 69, and Brian Kobilka, 57, for discovering the inner workings of G-protein-coupled receptors, which allow cells to respond to chemical messages such as adrenaline rushes.

"Around half of all medications act through these receptors, among them beta blockers, antihistamines and various kinds of psychiatric medications," the committee said.

Working out better ways to target the receptors, known as GPCRs, is an area of keen focus for pharmaceutical and biotechnology companies.

Lefkowitz told a news conference by telephone he was asleep when the phone call came from Sweden.

"I did not hear it - I must share with you that I wear earplugs to sleep. So my wife gave me an elbow. So there it was, a total shock and surprise," he said.

Sven Lidin, Professor of Inorganic Chemistry at Lund University and chairman of the committee, told a news conference the discovery had been key in medical research.

"Knowing what they (the receptors) look like and how they function will provide us with the tools to make better drugs with fewer side effects," he added.

GPCRs are linked to a wide range of diseases, since they play a central role in many biological functions in the body, but developing new drugs to target them accurately has been difficult because of a lack of fundamental understanding as to how they function. Experts say the work of the Nobel Prize winners has opened the door to making better medicines.

Drugs targeting GPCRs have potential in treating illnesses involving the central nervous system, heart conditions, inflammation and metabolic disorders.

Continued here:
Cell receptor research wins Americans chemistry Nobel

Research by Robert J. Lefkowitz, left, and Brian K. Kobilka has increased understanding of how cells sense chemicals.

STORY HIGHLIGHTS

(CNN) -- Two American scientists won the Nobel Prize in chemistry Wednesday for their work revealing protein receptors that tell cells what is going on in and around the human body. Their achievements have allowed drug makers to develop medication with fewer side effects.

Research spanning four decades by Robert J. Lefkowitz and Brian K. Kobilka on "G-protein-coupled receptors" has increased understanding of how cells sense chemicals in the bloodstream and external stimuli like light, according to the Royal Swedish Academy of Sciences, which awarded the prize.

Lefkowitz began the research by tracking adrenalin receptors. The Nobel Prize announcement apparently set off some of the excitement hormone in his own body.

"I'm feeling very, very excited," he said in a predawn phone call from the United States to the committee in Stockholm, Sweden, which announced the winners at 5:45 a.m. ET.

"Did I even have any inkling that it was coming?" Lefkowitz said. "I'd have to say no."

He contacted Kobilka via a Skype video call to celebrate the news after receiving the call from the Nobel committee.

Lefkowitz, with the Howard Hughes Medical Institute and Duke University Medical Center in Durham, North Carolina, began tracking cell receptors with radioactive substances in 1968.

In the 1980s, Kobilka, from Stanford University School of Medicine in California, joined the research to isolate the human gene that produces the adrenalin receptor, the academy said.

Read the original:
Americans win Nobel Prize in chemistry